Basal Cell Carcinoma Nevus Syndrome

BCCNS’ UNMET NEED

4905 Westshore Blvd.
Tampa, FL 33611

Our Mission

Inhibitor Therapeutics, Inc. (“INHIBITOR”) is a pharmaceutical development company focused on developing and commercializing innovative therapies based on already approved active pharmaceutical ingredients for novel, clinically valuable, and patent-protected indications. Our lead product is itraconazole for a hereditary, cancer syndrome (Gorlin’s syndrome) which is an orphan disease.

Home
Who We Are
Pipeline
Investors & Media
Contact Us
Terms of Use and Privacy Policy